Latest news with #AristocratLeisure
Yahoo
27-06-2025
- Business
- Yahoo
Why Light & Wonder Stock Blasted 10% Higher Today
The company had a good day in court. It's being sued by a peer who's alleging intellectual property misappropriation. 10 stocks we like better than Light & Wonder › Gaming technology stock Light & Wonder (NASDAQ: LNW) -- formerly known as Scientific Games -- proved to be quite the solid bet on Wednesday. On some very positive news in the legal sphere, investors piled into the company's shares, pumping them more than 10% higher in price. That looked especially good when compared to the S&P 500's (SNPINDEX: ^GSPC) flatline performance. Light & Wonder is currently locked in a legal dispute with peer company Aristocrat Leisure. Aristocrat is accusing it of copying elements from one of its casino slot games in the design of Light & Wonder's Dragon Train game. On Wednesday, the Nevada court in which the case is being heard made a ruling on discovery that favors Light & Wonder. It ruled that the company will not have to reveal its math models on the slot games in question. In addition, the court asked for specificity from Aristocrat regarding the trade secrets it's litigating to protect. Aristocrat, which is headquartered in Australia, brought its case against the American company in 2024. At the time, it stated in a press release that it "will seek all appropriate remedies to address the harm caused by Light & Wonder's actions." Light & Wonder had, understandably, been fairly quiet about the case. Perhaps it'll speak up more now that it seems to be tilting in its favor. Having said that, I wouldn't be ready to break out the champagne if I were a shareholder, at least not yet. Court cases can develop and resolve in unexpected ways, and Light & Wonder isn't out of the woods. I don't think anyone should buy or sell the company's stock based on predictions of the lawsuit's outcome. Before you buy stock in Light & Wonder, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Light & Wonder wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $689,813!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $906,556!* Now, it's worth noting Stock Advisor's total average return is 809% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Light & Wonder. The Motley Fool has a disclosure policy. Why Light & Wonder Stock Blasted 10% Higher Today was originally published by The Motley Fool


Business Insider
25-06-2025
- Business
- Business Insider
Aristocrat Leisure (ARLUF) Receives a Buy from Bell Potter
In a report released today, Baxter Kirk from Bell Potter maintained a Buy rating on Aristocrat Leisure (ARLUF – Research Report), with a price target of A$79.00. The company's shares closed last Friday at $41.41. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Kirk is an analyst with an average return of -4.8% and a 50.00% success rate. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aristocrat Leisure with a $46.74 average price target, representing a 12.87% upside. In a report released yesterday, Morgans also maintained a Buy rating on the stock with a A$71.00 price target. ARLUF market cap is currently $27.09B and has a P/E ratio of 29.52.


The Guardian
24-06-2025
- Health
- The Guardian
‘Tricky ethical space': endometriosis centre funded by family with links to poker machine giant divides experts
A $50m pledge to 'revolutionise endometriosis research' by a family with links to a poker machine giant has divided academics and public health experts, who believe universities should distance themselves from the gambling industry. But other university staff cite a 'moral obligation' to immediately use the money to ease the suffering of roughly 1 million Australian women living with endometriosis, rather than wait for 'perfect funding sources'. The University of New South Wales announced in May it had secured a 10-year funding commitment from the Ainsworth family to establish the 'world-first' Ainsworth Endometriosis Research Institute, which aims to 'accelerate breakthroughs in diagnosis and create precision-based treatments'. According to the university, three generations of the Ainsworth family have supported the initiative, including Len Ainsworth, who founded what became the world's largest poker machines manufacturer, Aristocrat Leisure, in 1958. Len Ainsworth also founded Ainsworth Game Technology, a smaller poker machine manufacturer. Sign up for Guardian Australia's breaking news email The institute's creation has been praised by academics and public health campaigners who are simultaneously concerned by the damaged caused by poker machines in Australia. In the first three months of this year, NSW residents lost an average of $24m a day to the state's nearly 90,000 machines. Andrew Hayen, a professor of biostatistics at University of Technology Sydney, described endometriosis as 'an area of women's health that is long overdue for investment' but also sought to raise 'uncomfortable questions' about 'the ethics of investment'. 'Poker machines are a key driver of gambling addiction, financial distress, family violence and mental ill health,' Hayen said in a LinkedIn post. 'These harms are not abstract. They are experienced every day by individuals and families, many of them women. 'There is no doubt that more funding is urgently needed for endometriosis research. But accepting philanthropic donations sourced from an industry built on public harm creates a troubling contradiction. 'It is hard to imagine any university in Australia today accepting donations from the tobacco industry. We should apply a similar level of scrutiny here.' Akeel Feroz, a manager of partnerships and innovation at UNSW Canberra who was not involved in the fundraising negotiations, said Hayen had raised 'a valid concern' but said 'our moral obligation must be to the patients suffering today'. 'The women waiting years for diagnosis don't have the luxury of perfect funding sources, they need solutions now,' Feroz said. 'With proper research safeguards in place, this funding could have a tremendous positive impact on the lives of women.' Kate Da Costa, who leads Wesley Mission's gambling advocacy, said the charity had refused to accept philanthropy linked to poker machines as 'we can't campaign to minimise gambling harm while taking their money'. 'Although it's a very tricky ethical space to start to navigate, those of us in gambling reform can take heart that at least the conversations are now under way,' Da Costa said in response to Hayen's post on LinkedIn. A UNSW spokesperson said it had accepted the philanthropic support in 'good faith' with the 'expectation and intention' the contribution would positively affect the university. 'All donations are assessed per the UNSW gift acceptance policy, which considers reputational, ethical and legal factors,' they said. The spokesperson said over the past decade the support of the Ainsworth family had enabled a range of initiatives including cancer research scholarships, student facilities and engineering teaching and learning spaces – including the university's the Ainsworth Building, which hosts its engineering department. Other academics, including Poppy Watson from the University of Technology Sydney, said the partnership demonstrated the state of academic and research funding in Australia. 'Sadly, with the current funding decline for science in Australia, all universities and the government see philanthropic investment as the best possible way to continue funding scientific research,' Watson said. 'In reality, aren't most incredibly wealthy donors rich off someone else's back?' Four Ainsworth family members listed by the UNSW as contributors are directors of the newly created Grevillea Foundation, which helped establish the institute at UNSW and seeks to 'transform the lives of those affected by endometriosis today and into the future'. Grevillea Foundation and its directors were contacted for comment. Roughly 1 million Australian women are living with endometriosis and often experience lengthy delays and frustration before they are properly diagnosed, according to the not-for-profit charity EndoActive. The condition causes 40,000 hospital admissions each year and it says hundreds of thousands of other women are regularly in pain.


Business Insider
24-06-2025
- Business
- Business Insider
Aristocrat Leisure (ARLUF) Receives a Buy from Morgans
Morgans analyst Leo Partridge maintained a Buy rating on Aristocrat Leisure (ARLUF – Research Report) today and set a price target of A$71.00. The company's shares closed last Friday at $41.41. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Partridge is an analyst with an average return of -1.5% and a 44.00% success rate. Partridge covers the Consumer Cyclical sector, focusing on stocks such as Aristocrat Leisure , Jumbo Interactive Limited, and BlueBet Holdings Ltd.. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aristocrat Leisure with a $46.36 average price target.
Yahoo
11-06-2025
- Business
- Yahoo
Do Its Financials Have Any Role To Play In Driving Aristocrat Leisure Limited's (ASX:ALL) Stock Up Recently?
Most readers would already be aware that Aristocrat Leisure's (ASX:ALL) stock increased significantly by 5.0% over the past week. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. Specifically, we decided to study Aristocrat Leisure's ROE in this article. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Aristocrat Leisure is: 16% = AU$1.2b ÷ AU$7.2b (Based on the trailing twelve months to March 2025). The 'return' is the income the business earned over the last year. So, this means that for every A$1 of its shareholder's investments, the company generates a profit of A$0.16. View our latest analysis for Aristocrat Leisure Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. To start with, Aristocrat Leisure's ROE looks acceptable. Further, the company's ROE compares quite favorably to the industry average of 8.0%. However, for some reason, the higher returns aren't reflected in Aristocrat Leisure's meagre five year net income growth average of 4.4%. This is generally not the case as when a company has a high rate of return it should usually also have a high earnings growth rate. We reckon that a low growth, when returns are quite high could be the result of certain circumstances like low earnings retention or poor allocation of capital. As a next step, we compared Aristocrat Leisure's net income growth with the industry and were disappointed to see that the company's growth is lower than the industry average growth of 41% in the same period. Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. Has the market priced in the future outlook for ALL? You can find out in our latest intrinsic value infographic research report. While Aristocrat Leisure has a decent three-year median payout ratio of 34% (or a retention ratio of 66%), it has seen very little growth in earnings. Therefore, there might be some other reasons to explain the lack in that respect. For example, the business could be in decline. Moreover, Aristocrat Leisure has been paying dividends for at least ten years or more suggesting that management must have perceived that the shareholders prefer dividends over earnings growth. Our latest analyst data shows that the future payout ratio of the company over the next three years is expected to be approximately 33%. Still, forecasts suggest that Aristocrat Leisure's future ROE will rise to 26% even though the the company's payout ratio is not expected to change by much. Overall, we feel that Aristocrat Leisure certainly does have some positive factors to consider. However, given the high ROE and high profit retention, we would expect the company to be delivering strong earnings growth, but that isn't the case here. This suggests that there might be some external threat to the business, that's hampering its growth. That being so, the latest analyst forecasts show that the company will continue to see an expansion in its earnings. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.